Join our daily newsletter At The Bell to receive exclusive market insights
- Beamtree (BMT) partners with the Central Adelaide Local Health Network (CALHN) to implement AI products to support safer care for patients
- The companies will implement a data quality product across CALHN’s hospital network as well as launch a new trial using RippleDown
- The trial supports clinical decision making for pathology services and will integrate the Ainsoff Index into the electronic medical record
- The collaboration also involves assessing RippleDown in clinical workflow to get feedback from practicing doctors
- Company shares end the day 20.2 per cent in the green to close at 59.5 cents
Beamtree (BMT) has partnered with the Central Adelaide Local Health Network (CALHN).
The partnership will see the pair implement artificial intelligence (AI) products to support better and safer care for patients.
Specifically, the companies will implement the RISQ data quality product across CALHN’s network of four hospitals. RISQ is a comprehensive measurement and auditing tool which supports better health data accuracy and the management of potential hospital-acquired complications.
Beamtree and CALHN will also launch a new trial using RippleDown, an AI decision support product, and launch the Ainsoff index which is used to detect deterioration in its early stage.
BMT CEO, Tim Kelsey, commented on the partnership.
“This strategic partnership is an outcome of our commitment to improving patient outcomes through the early identification of risk, benchmarking and AI-led decision support. Together, we have the opportunity to enhance healthcare service quality, safety, accuracy and insight that will improve health systems in Adelaide and beyond.”
Over the next six months, the companies will conduct a trial using RippleDown to support clinical decision making for pathology services and will integrate the Ainsoff Index into the electronic medical record. This is the first public hospital implementation of the Ainsoff Index since Beamtree acquired Ainsoff last month.
Beamtree Clinical Lead surgeon, Dr Levi Bassin, commented on the implementation of the Ainsoff Index.
“The implementation of the Ainsoff Index for deterioration in one of Australia’s largest public hospitals is a great step forward and clearly demonstrates the value of joining with Beamtree to gain broader support for implementations, ultimately helping more patients and clinicians across Australia.”
The collaboration also comes with the opportunity to co-develop a new implementation of RippleDown in clinical workflow. The aim of this will be to get feedback from practicing doctors to ensure the tool supports diagnostic ordering for safety and quality.
The revenue of the implementation will be over $300,000 to establish the proof of concept in the public health setting.
Company shares were up 20.2 per cent to close at 59.5 cents.
